Literature DB >> 32386579

Reconnecting for our future: The Lancet One Health Commission.

John H Amuasi1, Tamara Lucas2, Richard Horton2, Andrea S Winkler3.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 32386579      PMCID: PMC7252112          DOI: 10.1016/S0140-6736(20)31027-8

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
The evolution and sustenance of our planet hinges on a symbiotic relationship between humans, animals, and the environment that we share—we are interconnected. However, this past century has seen human dominance over the biosphere, manifest in technological innovations, accelerated mobility, and converted ecosystems that characterise industrialisation, globalisation, and urbanisation. These developmental trajectories have advanced human health in unprecedented ways. However, they also make humans increasingly vulnerable to contemporary global health challenges, such as emerging and re-emerging infectious diseases, as shown by the coronavirus disease 2019 (COVID-19) pandemic, antimicrobial resistance (AMR), and the increasing burden of non-communicable diseases. These challenges are further impacted by climate change, poverty, conflict, and migration. The apparent dominance of the human species comes with a huge responsibility. Thus, in our quest to ensure the health and continued existence of humanity, consideration must be given to the complex interconnectedness and interdependence of all living species and the environment—the concept of One Health.6, 7, 8 One Health highlights the synergistic benefit of closer cooperation between the human, animal, and environmental health sciences, as well as the importance of dismantling disciplinary and professional silos. The One Health concept has been recognised and promoted by the UN, the G20, and WHO, among several others. The Sustainable Development Goals in themselves can be understood as embodying a One Health strategy aimed at healthy people living on a perpetually habitable planet. The Lancet One Health Commission comprises 24 Commissioners (appendix) and several researchers from multiple disciplines from around the globe. The Commission's inaugural meeting was held in Oslo, Norway, in May, 2019. The Centre for Global Health at the University of Oslo, Norway, hosts the northern secretariat, with the support of the Center for Global Health at the Technical University of Munich, Germany. The Global Health group at the Kumasi Centre for Collaborative Research in Tropical Medicine on the Kwame Nkrumah University of Science and Technology campus, Kumasi, Ghana, hosts the southern secretariat. The Lancet One Health Commission aims for transdisciplinary and interdisciplinary collaboration to promote original thinking and generate solutions to the complex global health challenges of modern times, most of which require a One Health approach. The Commission's work is expected to offer a recalibrated understanding of the ways in which these global health challenges are implicated within the complex interconnectedness of humans, animals, and our shared environment, and to provide an approach for harnessing this knowledge to ensure a sustainably healthy future for all species, and the planet we inhabit. The main objective of The Lancet One Health Commission is to synthesise the evidence supporting a One Health approach to enhancing health within an environment shared by humans and animals. The Commission's work will explicate the significance of a One Health approach for policy by engaging transdisciplinary expertise and perspectives from both the public and private sectors. The Commission will explore global health challenges through a One Health lens, directing attention to infectious diseases, AMR, and non-communicable diseases—the latter of which have often been left out of the discourse on One Health. In proposing policy, implementation, and governance recommendations, the Commission will emphasise sociopolitical dimensions of health that are crucial for engaging and educating communities. Similarly, the Commission will promote leadership to build consensus among disparate sectors and foster champions for cohesion and change. Novel financing mechanisms will be assessed because these are key for building resilient health systems nationally and internationally. Conclusions from the Commission are anticipated to be integrated in policy briefs, international guidelines and protocols, and various high-level global health resolutions. At the core of The Lancet One Health Commission's work is our recognition of several possible approaches to examining the animal–environment–human interface, which we distil into three distinct but interrelated dimensions (figure ).
Figure

Approach of The Lancet One Health Commission

Approach of The Lancet One Health Commission The first dimension is the shared environment. We will consider how animals, including livestock, wildlife, and companions, share a common environment with humans in both rural and urban settings. We further explore the positive and negative implications of human activities and human–animal interactions for the shared environment. Within this space, zoonotic and emerging infectious diseases, as well as non-communicable diseases and mental health, will be considered. The second dimension is safe food and food systems. People rely on animals both as food and to help produce food. As such, the link between One Health and food safety and security will be explored. Among other things, the Commission will critically examine evidence for the hypothesised link between AMR and agricultural practices and we will proffer policy recommendations for scientific work to measure the association using innovative research methods.13, 14 The third dimension is shared medicines and interventions. Several drugs used to treat health conditions in humans originated from animal agriculture—eg, praziquantel and ivermectin. The potential for a more integrated approach to the implementation of health interventions that target both animals and people will be explored. Each of these three dimensions will be examined in relation to infectious diseases, non-communicable diseases, and AMR (figure). Operationalising One Health will require integrated animal and human health systems, including surveillance; robust modelling efforts that use big data for animals, humans, and plants; and engagements with digital health. Now more than ever with the COVID-19 pandemic, concerted knowledge and evidence generation must inform and catalyse responsive leadership, context-driven governance, progressive policy, and legislation that are sensitive to gender, community, equity, and ethics (figure). This work is vital for ensuring a sustainably reconnected approach to defending and synergistically enhancing the health of humans, animals, and our shared environment.
  11 in total

1.  Dilemmas in drug development for tropical diseases. Experiences with praziquantel.

Authors:  M R Reich; R Govindaraj
Journal:  Health Policy       Date:  1998-04       Impact factor: 2.980

Review 2.  Antimicrobial resistance: a global multifaceted phenomenon.

Authors:  Francesca Prestinaci; Patrizio Pezzotti; Annalisa Pantosti
Journal:  Pathog Glob Health       Date:  2015-09-07       Impact factor: 2.894

3.  The Sustainable Development Goals: One-Health in the World's Development Agenda.

Authors:  Lawrence O Gostin; Eric A Friedman
Journal:  JAMA       Date:  2015 Dec 22-29       Impact factor: 56.272

4.  Anti-parasite drugs sweep Nobel prize in medicine 2015.

Authors:  Ewen Callaway; David Cyranoski
Journal:  Nature       Date:  2015-10-08       Impact factor: 49.962

5.  Potential of cooperation between human and animal health to strengthen health systems.

Authors:  Jakob Zinsstag; Esther Schelling; Kaspar Wyss; Mahamat Bechir Mahamat
Journal:  Lancet       Date:  2005-12-17       Impact factor: 79.321

6.  One health security: an important component of the global health security agenda.

Authors:  Gigi Gronvall; Crystal Boddie; Rickard Knutsson; Michelle Colby
Journal:  Biosecur Bioterror       Date:  2014 Sep-Oct

7.  Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.

Authors: 
Journal:  Lancet       Date:  2018-11-10       Impact factor: 79.321

8.  The 2017 Oslo conference report on neglected tropical diseases and emerging/re-emerging infectious diseases - focus on populations underserved.

Authors:  Katharina Klohe; John Amuasi; Joyce Moriku Kaducu; Ingeborg Haavardsson; Ekaterina Bogatyreva; Kristine Husøy Onarheim; Wendy Harrison; Frederik Kristensen; Clarissa Prazeres da Costa; Andrea S Winkler
Journal:  Infect Dis Poverty       Date:  2019-05-28       Impact factor: 4.520

9.  Infectious disease emergence and global change: thinking systemically in a shrinking world.

Authors:  Colin D Butler
Journal:  Infect Dis Poverty       Date:  2012-10-25       Impact factor: 4.520

Review 10.  Antimicrobial Resistance in Agriculture.

Authors:  Sophie Thanner; David Drissner; Fiona Walsh
Journal:  mBio       Date:  2016-04-19       Impact factor: 7.867

View more
  13 in total

Review 1.  A Rapid Review of Environmental Health Gaps in Antimicrobial Resistance and Water-Related Research from 1990-2020.

Authors:  Lina Taing; Himesh Bhatia; Rachel A Kaiser; Manzoor Qadir; Hamid Mehmood
Journal:  Int J Environ Res Public Health       Date:  2022-05-27       Impact factor: 4.614

Review 2.  Towards a global One Health index: a potential assessment tool for One Health performance.

Authors:  Xiao-Xi Zhang; Jing-Shu Liu; Le-Fei Han; Shang Xia; Shi-Zhu Li; Odel Y Li; Kokouvi Kassegne; Min Li; Kun Yin; Qin-Qin Hu; Le-Shan Xiu; Yong-Zhang Zhu; Liang-Yu Huang; Xiang-Cheng Wang; Yi Zhang; Han-Qing Zhao; Jing-Xian Yin; Tian-Ge Jiang; Qin Li; Si-Wei Fei; Si-Yu Gu; Fu-Min Chen; Nan Zhou; Zi-Le Cheng; Yi Xie; Hui-Min Li; Jin Chen; Zhao-Yu Guo; Jia-Xin Feng; Lin Ai; Jing-Bo Xue; Qian Ye; Liz Grant; Jun-Xia Song; Geoff Simm; Jürg Utzinger; Xiao-Kui Guo; Xiao-Nong Zhou
Journal:  Infect Dis Poverty       Date:  2022-05-22       Impact factor: 10.485

Review 3.  The Integration of Human and Veterinary Studies for Better Understanding and Management of Crimean-Congo Haemorrhagic Fever.

Authors:  Ciaran Gilbride; Jack Saunders; Hannah Sharpe; Emmanuel Atangana Maze; Georgina Limon; Anna Barbara Ludi; Teresa Lambe; Sandra Belij-Rammerstorfer
Journal:  Front Immunol       Date:  2021-03-18       Impact factor: 7.561

4.  Effectiveness of a school-based programme of animal-assisted humane education in Hong Kong for the promotion of social and emotional learning: A quasi-experimental pilot study.

Authors:  Joe T K Ngai; Rose W M Yu; Kathy K Y Chau; Paul W C Wong
Journal:  PLoS One       Date:  2021-03-19       Impact factor: 3.240

5.  Brain Health, One Health, and COVID-19.

Authors:  David O Wiebers; Valery L Feigin; Andrea S Winkler
Journal:  Neuroepidemiology       Date:  2021-10-11       Impact factor: 3.282

6.  Effect of Intramuscularly Administered Oxytetracycline or Enrofloxacin on Vancomycin-Resistant Enterococci, Extended Spectrum Beta-Lactamase- and Carbapenemase-Producing Enterobacteriaceae in Pigs.

Authors:  Elena González-Fandos; Alba Martínez-Laorden; Ana Abad-Fau; Eloisa Sevilla; Rosa Bolea; María Jesús Serrano; Olga Mitjana; Cristina Bonastre; Alicia Laborda; María Victoria Falceto; Rafael Pagán
Journal:  Animals (Basel)       Date:  2022-03-01       Impact factor: 2.752

7.  Using the Kolb's experiential learning cycle to explore the extent of application of one health competencies to solving global health challenges; a tracer study among AFROHUN-Uganda alumni.

Authors:  Tonny Ssekamatte; John Bosco Isunju; Aisha Nalugya; Richard K Mugambe; Patrick Kalibala; Angella Musewa; Winnie Bikaako; Milly Nattimba; Arnold Tigaiza; Doreen Nakalembe; Jimmy Osuret; Solomon Tsebeni Wafula; Esther Buregyeya; Fatima Tsiouris; Susan Michaels-Strasser; John David Kabasa; William Bazeyo
Journal:  Global Health       Date:  2022-05-12       Impact factor: 10.401

8.  The Health Equity Network of the Americas: inclusion, commitment, and action.

Authors:  Arachu Castro; Rocío Sáenz; Ximena Avellaneda; Carlos Cáceres; Luiz Galvão; Pedro Mas; Amy E Ritterbusch; Manuel Urbina Fuentes
Journal:  Rev Panam Salud Publica       Date:  2021-07-01

9.  Does an Antibiotic Stewardship Applied in a Pig Farm Lead to Low ESBL Prevalence?

Authors:  Claudine Fournier; Patrice Nordmann; Olivier Pittet; Laurent Poirel
Journal:  Antibiotics (Basel)       Date:  2021-05-13

Review 10.  A One Health strategy for emerging infectious diseases based on the COVID-19 outbreak.

Authors:  Qin Wu; Qianlin Li; Jiahai Lu
Journal:  J Biosaf Biosecur       Date:  2021-10-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.